ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma

Am J Dermatopathol. 2022 May 1;44(5):376-379. doi: 10.1097/DAD.0000000000002168.

Abstract

Primary cutaneous anaplastic large-cell lymphoma (C-ALCL) is a cutaneous CD30-positive lymphoproliferative disorder. The patients usually present with single or multiple cutaneous nodules or papules and about 10% cases present with extracutaneous manifestations, which are predominantly in the form of regional lymph nodal involvement. Visceral involvement especially pulmonary or hepatic involvement in C-ALCL is only rarely described in the scientific literature. Approximately 20%-42% cases show spontaneous regression, about 50% cases may recur; however, C-ALCL generally carries a good prognosis. We present a rare case of primary C-ALCL in a 66-year-old man with regional lymph nodal and hepatic involvement. Differential diagnostic entities are discussed in this report with the review of the literature.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Humans
  • Lymphoma, Large-Cell, Anaplastic* / diagnosis
  • Lymphoma, Large-Cell, Anaplastic* / pathology
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell* / diagnosis
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell* / pathology
  • Lymphoproliferative Disorders* / pathology
  • Male
  • Neoplasm Recurrence, Local
  • Receptor Protein-Tyrosine Kinases
  • Skin Diseases*
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / pathology

Substances

  • Receptor Protein-Tyrosine Kinases